3 Pharmaceutical Stocks That Are Too Cheap to Ignore
On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities to get in on solid value stocks that are underpriced and offer solid dividends.
Viatris (NASDAQ: VTRS), (NYSE: GSK), and Organon (NYSE: OGN) are too inexpensive to pass up at this point. All three pharmaceutical stocks trade at under 7 times earnings and have forward price-to-earnings ratios of less than 10.
GSK PE Ratio data by YCharts.
Source Fool.com
GSK plc ADR Aktie
37,00 €
-0,54 %
Mit 6 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung steht die Community der GSK plc ADR Aktie positiv gegenüber.
Die Community erwartet für GSK plc ADR ein Kursziel von 49 €, was eine Steigerung von über 20% gegenüber 37.0 € bedeuten würde.
